Pharmacokinetics of meloxicam following intravenous administration at different doses in sheep
dc.authorid | Coskun, Alparslan/0000-0002-2242-9647 | |
dc.authorid | Coskun, Devran/0000-0003-1151-1861 | |
dc.authorid | Uney, Kamil/0000-0002-8674-4873 | |
dc.authorid | Yilmaz, Gokhan/0000-0001-6495-5488 | |
dc.authorid | Corum, Orhan/0000-0003-3168-2510 | |
dc.contributor.author | Gungor, Huseyin | |
dc.contributor.author | Corum, Orhan | |
dc.contributor.author | Corum, Duygu Durna | |
dc.contributor.author | Kumru, Alper Serhat | |
dc.contributor.author | Yilmaz, Gokhan | |
dc.contributor.author | Coskun, Devran | |
dc.contributor.author | Coskun, Alparslan | |
dc.date.accessioned | 2024-12-24T19:29:35Z | |
dc.date.available | 2024-12-24T19:29:35Z | |
dc.date.issued | 2024 | |
dc.department | Siirt Üniversitesi | |
dc.description.abstract | The aim of this study is to determine the pharmacokinetic change after intravenous administration of meloxicam at doses of 0.5, 1 and 2 mg/kg to sheep. The study was carried out on six Akkaraman sheep. Meloxicam was administered intravenously to each sheep at 0.5, 1, and 2 mg/kg doses in a longitudinal pharmacokinetic design with a 15-day washout period. Plasma concentrations of meloxicam were determined using the high performance liquid chromatography-ultraviolet, and pharmacokinetic parameters were evaluated by non-compartmental analysis. Meloxicam was detected up to 48 h in the 0.5 mg/kg dose and up to 96 h in the 1 and 2 mg/kg doses. As the dose increased from 0.5 to 2 mg/kg, terminal elimination half-life, and dose normalized area under the concentration versus time curve increased and total clearance decreased. Compared to the 1 mg/kg dose, it was determined that V(dss )decreased and C-0.083h increased in the 2 mg/kg dose. Meloxicam provided the therapeutic concentration of >0.39 mu g/mL reported in other species for 12, 48 and 96 h at 0.5, 1 and 2 mg/kg doses, respectively. These results show that meloxicam exhibits non-linear pharmacokinetics and will achieve unpredictable plasma concentrations when administered IV for a rapid effect at dose of >= 1 mg/kg in sheep. | |
dc.identifier.doi | 10.1111/jvp.13422 | |
dc.identifier.endpage | 207 | |
dc.identifier.issn | 0140-7783 | |
dc.identifier.issn | 1365-2885 | |
dc.identifier.issue | 3 | |
dc.identifier.pmid | 38033195 | |
dc.identifier.scopus | 2-s2.0-85178223399 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.startpage | 202 | |
dc.identifier.uri | https://doi.org/10.1111/jvp.13422 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12604/7152 | |
dc.identifier.volume | 47 | |
dc.identifier.wos | WOS:001111260300001 | |
dc.identifier.wosquality | Q2 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Wiley | |
dc.relation.ispartof | Journal of Veterinary Pharmacology and Therapeutics | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.snmz | KA_20241222 | |
dc.subject | increasing dose | |
dc.subject | meloxicam | |
dc.subject | pharmacokinetics | |
dc.subject | sheep | |
dc.title | Pharmacokinetics of meloxicam following intravenous administration at different doses in sheep | |
dc.type | Article |